Signalling networks regulating cyclooxygenase-2

被引:444
作者
Tsatsanis, Christos [1 ]
Androulidaki, Ariadne [1 ]
Venihaki, Maria [1 ]
Margioris, Andrew N. [1 ]
机构
[1] Univ Crete, Sch Med, Dept Clin Chem Biochem, GR-71003 Iraklion, Crete, Greece
关键词
COX-2; MAPK; inflammation; cancer; NSAID;
D O I
10.1016/j.biocel.2006.03.021
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cyclooxygenease-2 (COX-2) is the key enzyme regulating the production of prostaglandins, central mediators of inflammation. The expression of cyclooxygenease-2 is induced by several extra cellular signals including pro-inflammatory and growth-promoting stimuli. All signals converge to the activation of mitogen-activated protein kinases (MAPK) that regulate cyclooxygenease-2 mRNA levels both at the transcriptional and post-transcriptional level. The machinery appears to be highly specialized involving activation of distinct signalling molecules depending on the type of extracellular stimulus. Expression of cyclooxygenease-2 mRNA is regulated by several transcription factors including the cyclic-AMP response element binding protein (CREB), nuclear factor kappa B (NFkB) and the CCAAT-enhancer binding protein (C/EBP). Cyclooxygenease-2 is also affected post-transcriptionaly, at the level of mRNA stability. Finally, cyclooxygenease-2 can be affected directly at its enzymatic activity by nitric oxide and nitric oxide synthase (NOS). Each step of cyclooxygenease-2 regulation can be used as potential therapeutic target. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1654 / 1661
页数:8
相关论文
共 56 条
[41]  
Ramsay RG, 2003, INT J IMMUNOPATH PH, V16, P59
[42]   NITRIC-OXIDE ACTIVATES CYCLOOXYGENASE ENZYMES [J].
SALVEMINI, D ;
MISKO, TP ;
MASFERRER, JL ;
SEIBERT, K ;
CURRIE, MG ;
NEEDLEMAN, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (15) :7240-7244
[43]   Interleukin-1β-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity [J].
Samad, TA ;
Moore, KA ;
Sapirstein, A ;
Billet, S ;
Allchorne, A ;
Poole, S ;
Bonventre, JV ;
Woolf, CJ .
NATURE, 2001, 410 (6827) :471-475
[44]   Monocyte membrane type 1-matrix metalloproteinase - Prostaglandin-dependent regulation and role in metalloproteinase-2 activation [J].
Shankavaram, UT ;
Lai, WC ;
Netzel-Arnett, S ;
Mangan, PR ;
Ardans, JA ;
Caterina, N ;
Stetler-Stevenson, WG ;
Birkedal-Hansen, H ;
Wahl, LM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (22) :19027-19032
[45]   Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2 [J].
Sheng, HM ;
Shao, JY ;
Kirkland, SC ;
Isakson, P ;
Coffey, RJ ;
Morrow, J ;
Beauchamp, RD ;
DuBois, RN .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (09) :2254-2259
[46]   Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2 [J].
Smith, WL ;
Garavito, RM ;
DeWitt, DL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (52) :33157-33160
[47]   Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention [J].
Solomon, SD ;
McMurray, JJV ;
Pfeffer, MA ;
Wittes, J ;
Fowler, R ;
Finn, P ;
Anderson, WF ;
Zauber, A ;
Hawk, E ;
Bertagnolli, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (11) :1071-1080
[48]   Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals:: down-regulation of COX-2 and iNOS through suppression of NF-κB activation [J].
Surh, YJ ;
Chun, KS ;
Cha, HH ;
Han, SS ;
Keum, YS ;
Park, KK ;
Lee, SS .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2001, 480 :243-268
[49]   The spinal phospholipase-cyclooxygenase-prostanoid cascade in nociceptive processing [J].
Svensson, CI ;
Yaksh, TL .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2002, 42 :553-583
[50]   Analysis of gene and protein expression during monocyte-macrophage differentiation and cholesterol loading -: cDNA and protein array study [J].
Tuomisto, TT ;
Riekkinen, MS ;
Viita, H ;
Levonen, AL ;
Ylä-Herttuala, S .
ATHEROSCLEROSIS, 2005, 180 (02) :283-291